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Egress of non-enveloped enteric RNA viruses
Irene A. Owusu1,2, Osbourne Quaye2, Karla D. Passalacqua1,3 and Christiane E. Wobus1,*

Abstract
A long-standing paradigm in virology was that non-enveloped viruses induce cell lysis to release progeny virions. However,
emerging evidence indicates that some non-enveloped viruses exit cells without inducing cell lysis, while others engage both
lytic and non-lytic egress mechanisms. Enteric viruses are transmitted via the faecal–oral route and are important causes of
a wide range of human infections, both gastrointestinal and extra-intestinal. Virus cellular egress, when fully understood, may
be a relevant target for antiviral therapies, which could minimize the public health impact of these infections. In this review,
we outline lytic and non-lytic cell egress mechanisms of non-enveloped enteric RNA viruses belonging to five families: Picornaviridae, Reoviridae, Caliciviridae, Astroviridae and Hepeviridae. We discuss factors that contribute to egress mechanisms and
the relevance of these mechanisms to virion stability, infectivity and transmission. Since most data were obtained in traditional
two-dimensional cell cultures, we will further attempt to place them into the context of polarized cultures and in vivo pathogenesis. Throughout the review, we highlight numerous knowledge gaps to stimulate future research into the egress mechanisms
of these highly prevalent but largely understudied viruses.

non-enveloped, except for several enveloped enteric viruses
in the family Coronaviridae, including transmissible gastroenteritis virus (TEGV) and porcine deltacoronavirus (PdCV).
These viruses can induce cell lysis via necrosis in gastric pits
and small intestines in the case of PdCV [1], while TEGV
infection in intestinal epithelial cells induces mitophagy [2].
Although whether induction of necrosis or mitophagy are
required for viral release is not yet known.

INTRODUCTION
The presence or lack of a viral envelope is a critical factor in
the viral life cycle that distinguishes the cellular entry and
exit strategies of enveloped from non-enveloped viruses. The
lipid membrane and viral glycoproteins present in enveloped
viruses dictates membrane fusion following engagement with
cellular receptors for entry, and this structure typically leads
to non-lytic cell exit pathways such as budding and exocytosis, although exceptions exist. Most enteric viruses are
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In contrast, non-enveloped viruses traditionally have been
thought to be released lytically as a result of cell death; however,
recent evidence indicates that non-enveloped RNA and DNA
viruses can egress without lysing cells [3]. For instance, the
non-enveloped DNA virus BK polyomavirus can be released
through a non-lytic pathway while cellular anion homeostasis
is maintained in infected renal proximal tubule epithelial
(RPTE) cells [4]. Also, the non-enveloped RNA virus hepatitis
A virus (HAV) rarely causes cytolytic infections and instead
is non-lytically released as a ‘quasi-enveloped’ form [5]. The
quasi-envelope is a cell-derived enclosure that surrounds
non-enveloped virions, making them appear enveloped, but
lacks viral glycoproteins, unlike classical viral envelopes [6].
While this term was first coined for hepatitis viruses [7],
the functional characteristic (i.e. a lipid membrane devoid
of viral glycoproteins) extends to other membrane-wrapped
non-enveloped viruses. As detailed below, non-enveloped
viruses of the same family, or even the same virus, can exit
the same or different cell types in multiple ways. Therefore,
no inferences on the egress mechanism from a given cell type
or by a given virus can be made.

currently known egress mechanisms for the non-enveloped
enteric viruses discussed in this review.

Virus egress mechanisms
The way a virus exits a cell depends both on the virus itself and
the cell type being infected. Thus, the outcome of infection
of the same virus in different cell types is partly dictated by
the underlying cellular response. In this section, we discuss
three main mechanisms by which non-enveloped enteric
RNA viruses are released from cells. First, we focus on the
classical lytic release mechanism, where viruses exit infected
cells by killing cells either via apoptosis or necrosis. Second,
non-lytic release pathways, by which non-enveloped enteric
RNA viruses are released without activating cell death mechanisms, are discussed. Finally, we highlight non-lytic release of
viruses via cell-to-cell protrusions and discuss the directional
release of viruses from polarized cells.
Lytic virus release
Cell death can occur by multiple mechanisms, including apoptosis, necrosis and autophagy [15]. Apoptosis is an inherent
programmed cell death mechanism in cells of multicellular
organisms that is mediated by the formation of apoptotic
bodies, which minimizes exposure of cellular contents to
the extracellular space, thereby reducing the risk of inflammation [16]. Initiation of apoptosis occurs via an intrinsic
(mitochondrial) or extrinsic (death receptor) pathway, and
these converge in the activation of executioner caspases 3,
6, or 7. When proapoptotic molecules are released from the
mitochondria without involvement of caspases, a caspase-
independent cell death ensues [17]. Since most of the research
we reviewed examined the involvement of caspases in cell
death, this review will categorize apoptotic cell death into
caspase-dependent and caspase-independent apoptosis. In
addition, necrosis is a form of uncontrolled cell death initiated
by external stimuli that leads to the loss of plasma membrane
integrity, release of cellular contents, and a stronger inflammatory response than apoptosis [16, 18]. While pyroptosis
and necroptosis are other forms of cell death that each share
some characteristics with apoptosis and necrosis, a link to
enteric RNA virus release has not been demonstrated to
date. Thus, we will focus solely on apoptosis and necrosis.
Autophagy, which ultimately can lead to cell death, will also
be discussed as a means toward vesicle generation for non-
lytic virus release [19–22]. It is important to note that while
viral infections can cause host cell death in a variety of ways,
cell death may not be directly induced by viruses for their
release but may be an indirect consequence of virus-induced
cellular changes. However, for the purpose of this review, we
correlate host cell death and virus egress based on the observation of reduced virus release when apoptosis or necrosis is
inhibited. Much less is known about such a link in vivo, but
we point out the known examples.

Knowledge of viral egress mechanisms is important for our
understanding of pathogenesis, including viral entry and
infection, incubation period, disease outcome and progression, and viral transmission within and between hosts. For
instance, some non-enveloped viruses released non-lytically
in membrane-enclosed vesicles establish infections more
efficiently than native ‘naked’ virus particles [8]. Membrane
enclosure also allows for neutralizing antibody evasion [9], as
well as en bloc transmission of viruses. En bloc transmission
increases the chances of a productive infection by promoting
a higher infectious dose in instances where multiple viral
particles are enclosed within a vesicle [10]. Hence, understanding various egress mechanisms can inform prognosis
and management of viral infections and aid in the development of drugs or vaccines to block virus transmission.
Non-enveloped enteric RNA viruses comprise a group of
viral families that cause some common human diseases. For
instance, human noroviruses in the family Caliciviridae are
the leading cause of viral gastroenteritis globally and are
responsible for about 18 % of all gastroenteritis cases [11].
Coxsackievirus, echovirus and enterovirus 71, members of
the family Picornaviridae, are leading causes of viral meningitis and hand, foot and mouth disease, respectively [12–14].
Also, two important causes of viral hepatitis (hepatitis A
and E virus) are non-enveloped enteric RNA viruses. Thus,
non-enveloped enteric RNA viruses cause a significant public
health burden. Understanding how they are released provides
an insight into infection parameters, which has important
implications for disease management and prevention. Therefore, this review will focus on the cellular egress mechanisms
of faecal–orally transmitted non-enveloped RNA viruses
belonging to five families; Picornaviridae (coxsackievirus,
echovirus, encephalomyocarditis virus, enterovirus 71, hepatitis A virus/hepatovirus, poliovirus), Reoviridae (reovirus and
rotavirus), Caliciviridae (norovirus), Astroviridae (astrovirus)
and Hepeviridae (hepatitis E virus). Table 1, Fig. 1 outline

Caspase-dependent apoptosis

Caspase-dependent apoptosis occurs when an apoptotic
stimulus such as an infectious agent, an immune reaction, or
2

Owusu et al., Journal of General Virology 2021

Table 1. Non-enveloped enteric viruses with currently known egress mechanisms
Virus

Egress mechanism

Cell type

Reference

Caspase-dependent apoptosis

HeLa, COS-1

[25, 29, 30]

Caspase-independent apoptosis

HeLa

[86]

Necrosis

Caco-2

[88]

Secretory autophagosomes (AWOL)

HeLa, MEFs, skeletal myoblasts,
mouse atrial myocytes

[106, 107]

Protrusion-mediated cell-to-cell spread

GMK

[134]

Strain-dependent lytic and non-lytic
release

Monkey kidney cells

[141]

Necrosis

HeLa, BHK-21

[89, 90]

Exosomes

HeLa

[119]

Caspase-dependent apoptosis

RD, HeLa, HMEC-1, SF268

[24, 33]

Exosomes

Human neuroblastoma, RD, motor
neurons

[8, 113]

Caspase-dependent apoptosis

FRhK-4

[34]

Exosomes

Huh 7.5

[114]

Apical

Caco-2

[3]

Apical and basolateral release

HepG2

[115, 149, 150]

Caspase-dependent apoptosis

HeLa, U937

[26, 32, 85, 99]

Caspase-independent apoptosis

HeLa

[85]

Secretory autophagosomes

HeLa, human chorion cells, Huh,
COS-1

[100]
[19, 101–104]

Apical release

Polarized Caco-2

[148]

Apical and basolateral release

Polarized Vero

Caspase-dependent apoptosis

HEK293, HeLa NIH 3T3, L-929,
MEFs

[39–43, 48]

Apical release

Human respiratory epithelial cells,
HBMECs

[157, 159]

Caspase-dependent apoptosis

Caco-2, HT-29, MA104

[61]

Necrosis

MA104, L-929

[91, 92]

Microvesicles

Human cholangiocytes, MA104,
Caco-2

[10, 61]

Apical release

IPEC-J2
Caco-2

[160, 162]

Apical and basolateral release

MA104

Caspase-dependent apoptosis

Tuft cells, RAW 264.7, CrFK

[66–72]

Exosomes

Stool (in vivo), RAW 264.7

[10, 121]

Unclassified non-lytic release

Caco-2, HEK293T, A549

[136–139]

Picornaviridae
Coxsackievirus

Echovirus
Encephalomyocarditis virus (EMCV)

Enterovirus 71 (EV71)

Hepatitis A virus (HAV)

Poliovirus

Reoviridae
Reovirus

Rotavirus

Caliciviridae
Norovirus

Astroviridae
Human astrovirus

Continued
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Table 1. Continued
Virus

Egress mechanism

Cell type

Reference

Caspase-dependent apoptosis

HBMECs

[77]

Exosomes

PLC/PKF/5, A549

[122–125, 128]

Apical release

HepG2/C3A, Caco-2 cells

[130, 154]

Herpeviridae
Hepatitis E virus

a toxin induces the expression of Bax proteins. Bax in turn
activates the apoptotic cascade and mediates permeabilization
of the mitochondrial membrane for release of pro-apoptotic
factors, including cytochrome c. Cytochrome c then activates
a cascade of caspases to induce cellular changes such as DNA

fragmentation, nuclear pyknosis and chromatin condensation
[23]. Members of the Picornaviridae, Reoviridae, Caliciviridae
and Hepeviridae induce caspase-dependent apoptosis in
specific cell types, resulting in the release of virions into the
cell culture supernatant.

Fig. 1. Summary of currently known egress mechanisms of non-enveloped enteric RNA viruses discussed in the text. Created with
Biorender.
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Specifically, members of the family Picornaviridae, including
poliovirus, coxsackievirus, enterovirus 71 (EV71) and hepatitis A virus (HAV), induce caspase-dependent apoptosis via
activity of the viral non-structural protein 2B, resulting in
cell lysis of transformed epithelial cell lines and virion release
into the supernatant. EV71 2B localizes to the mitochondrial membrane to interact with and activate Bax [24], while
coxsackievirus B3 (CVB3) 2B disrupts calcium ion homeostasis to create lesions in the cellular membrane, leading
to the apoptotic release of virus progeny [25]. In addition,
poliovirus, CVB3 and EV71 can also use their 3C proteases
to induce caspase-
dependent apoptosis by unknown
mechanisms [26–30]. In the case of duck hepatitis A virus,
the structural protein VP3 induces the intrinsic pathway of
apoptosis in duck embryo fibroblasts upon transfection [31].
Whether the same proteins also mediate apoptotic release of
poliovirus and EV71 from human macrophage (U937) and
endothelial (HMEC-1) cells [32, 33], or HAV from foetal
rhesus kidney-4 (FRhK-4) cells [34], remains unknown. In
vivo, apoptosis contributes to pathogenesis because it is associated with poliovirus replication and damage to the central
nervous system during paralytic poliomyelitis in infected
mice [35] and humans [36, 37]. However, it is unclear
whether apoptosis is important for virus release in vivo. In
summary, egress of picornaviruses via caspase-dependent
apoptosis is at least in part mediated by the 2B viroporin
and/or 3C viral protease. The role of 2B protein in mediating
caspase-dependent apoptosis in infected cells is shared by
viroporins of other RNA viruses such as Sindbis virus (6K),
mouse hepatitis virus (E), influenza virus (M2) and hepatis
C virus (P7 and NS4A) [38].

(i.e. organ type) and viral (e.g. σ1s, μ1 and μ2 proteins) factors
mediate virus release.
During rotavirus infection in vitro, induction of caspase-
dependent apoptosis and virus release into the supernatant
is cell type- and cell differentiation-dependent (Table 1).
Infection of transformed human colon cancer cell lines
(Caco-2, HT-29) and MA104 cells (African green monkey
kidney) with simian rhesus rotavirus RRV and porcine rotavirus CRW-8 strains leads to typical apoptotic features, such
as DNA fragmentation, chromatin condensation, release of
apoptotic bodies, disruption of mitochondrial membrane
potential, release of cytochrome c and caspase activation
[57–61]. However, in Caco-2 cells, apoptosis only occurs in
fully differentiated cells [57, 59]. Induction of apoptosis is
mediated by the NSP4 protein of rotavirus, which translocates to and disrupts the mitochondrial membrane, causing
release of cytochrome c and triggering caspase activation
[62]. NSP4 also triggers dynamic Ca2+ signalling [63], which
when prolonged results in cell lysis. In vivo, rotavirus infection causes apoptosis of infected enterocytes, which underlies
the pathobiology of disease, including villus atrophy [64].
The loss of dying cells from the intestinal epithelium in turn
may mediate viral dissemination to new hosts. In summary,
induction of caspase-dependent apoptosis by members of the
family Reoviridae is mediated either by structural proteins
(i.e. reovirus μ1 and μ2), or non-structural proteins (i.e. rotavirus NSP4, reovirus σ1s) in vitro and in vivo, highlighting the
importance of this function during infection.
In the case of caliciviruses, murine norovirus (MNV) infection
of murine macrophages and dendritic cells causes cytopathic
effect (CPE) [65], suggesting that these viruses induce cell
death to enable egress. The visible CPE and loss of cell viability
seen with propidium iodide staining was also observed with
MNV infection in an immature B cell line (WEHI-231)
[66]. Optimal virus release of MNV from infected murine
macrophages (RAW 264.7 cells) is due to caspase-mediated
apoptosis, which is tightly regulated by the virulence factor
1 (VF1) and downregulation of the anti-apoptotic protein
survivin by a yet unidentified viral non-structural protein
[67–70]. Similarly, feline calicivirus (FCV) downregulates
survivin and XIAP (X-linked inhibitor of apoptosis protein) to
induce caspase-dependent apoptosis in feline kidney (CrFK)
cells [71]. Downregulation of survivin is mediated by the FCV
leader capsid (LC) protein [71]. In vivo, the persistent MNV
strain CR6, but not the acute MNV-1 strain, induces apoptotic
cell death of tuft cells for sustained shedding and transmission
of virus in faeces [72, 73], representing an example that links
apoptosis to virus release from the host.

Caspase-dependent apoptosis and virus egress occur in
Reoviridae (reovirus and rotavirus) infection via different
mechanisms. Reovirus infection can induce caspase-mediated
apoptosis in transformed and primary cells in vitro [39–48],
depending on the virus strain. These virus strain-specific
differences in the ability to induce apoptosis are linked to the
S1 and M2 gene segments, encoding the viral cell attachment
protein, σ1, and a small non-structural protein, σ1s, as well as
the major outer capsid protein, μ1, respectively [49].
In vivo, reovirus-induced apoptosis in the heart and nervous
system is mediated by σ1s [50]. This viral protein localizes to
the nucleus of cells to disrupt the nuclear landscape, including
the A-type nuclear lamin-network (La A/C) [51]. Disruption
of La A/C in heart muscle cells weakens the nucleus, which,
coupled with the constant mechanical stress of a beating
heart, drives cells towards apoptosis [52]. In the nervous
system, σ1s enhances cell cycle arrest at the G2/M phase to
inhibit proliferation of reovirus-infected neurons, resulting in
apoptosis [53–55]. Whether apoptosis in these organs leads
to virus release remains unknown. This contrasts with the
intestine, where apoptosis is linked to virus release. Specifically, the non-apoptotic strain of reovirus T1L persists in the
intestine, while the apoptotic strain T3D-RV is cleared more
rapidly due to the sloughing off of infected apoptotic cells
[56]. Induction of apoptosis in the intestine is mediated by
the M1 and M2 viral genes [56]. Thus, for reoviruses, host

For human norovirus (HNoV), the strongest evidence that
infection induces caspase-dependent apoptosis comes from
analysis of intestinal biopsies from HNoV-infected individuals that showed evidence of DNA fragmentation and caspase
activation in duodenal epithelial cells [74]. However, whether
apoptosis is required for virion release is unknown. In vitro,
HNoV-infected human intestinal enteroids show limited cell
rounding and cell death [75], and no cell death is detected
5
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deformation during caspase inhibition, indicating that
apoptotic cell death does not solely depend on caspase
activation in HeLa cells. Unlike in caspase-dependent
apoptosis, where the 3C and 2B viral proteins are involved
in inducing the process, no viral protein(s) has been implicated in caspase-independent apoptosis in picornaviruses.
Thus, although these viruses can induce both caspase-
dependent and- independent apoptosis, the factors that
determine the type of apoptotic cell death induced during
an infection and the regulation of these pathways are
unknown.

in mature B-cell cultures infected with HNoV [66]. Thus,
while HNoV can cause cell death in vivo, permissive cells in
culture do not exhibit widespread CPE, suggesting an alternative egress pathway under these conditions. Collectively,
studies to date indicate that Caliciviridae induce lytic release
via caspase-dependent apoptosis following downregulation
of survivin by structural (FCV) or non-structural proteins
(MNV). Future studies are needed to determine the molecular
mechanism and viral mediators of HNoV-induced apoptosis.
Hepatitis E virus (HEV) causes cell injury by inducing an
intrinsic caspase-mediated apoptotic pathway in the liver
[76] and brain in vivo and in primary human brain microvasculature endothelial cells in vitro [77]. Tissue sections
from HEV-infected Mongolian gerbils showed increased
TUNEL staining and increased expression of caspase-9,
caspase-3 and the pro-apoptotic protein Bax, a finding
also made in vitro [77]. Apoptotic cell death and associated
tissue injury in the brain and liver may account for the
neurological disorders and hepatitis associated with HEV
infection [78, 79]. However, whether cellular apoptosis
is required for HEV release and transmission or the viral
proteins triggering apoptosis remain to be explored.

Necrosis

Necrosis is a form of cell death that occurs with the loss
of plasma membrane integrity that is preceded by swelling
of cellular organelles, ultimately leading to the release of
cellular contents to the extracellular space [16, 18]. The
exposure of cytoplasmic content during necrosis provokes
an inflammatory response around the dying cell that
catalyses pathological processes [87]. Necrotic cells generally exhibit vacuolation of the cytoplasm, breakdown of the
plasma membrane and changes in nuclear morphology, but
not DNA fragmentation and chromatin condensation, as
seen in apoptosis [15]. Calpain and cathepsin are major
proteases involved in necrotic cell death [18]. Viruses in
the families Picornaviridae and Reoviridae induce necrosis
for viral release and spread.

In summary, caspase-dependent apoptosis is induced by
many non-
enveloped RNA viruses, resulting in virion
release into the cell culture supernatant. In vivo, apoptosis
of virus-infected intestinal epithelial cells is an important
characteristic of pathogenesis, as it ensures virion release
and subsequent transmission to new hosts. Initiation of this
process typically occurs via the intrinsic pathway, given the
obligate intracellular nature of viruses, and is mediated by
specific non-structural or structural viral proteins, depending
on the virus species.

The Picornaviridae members CVB1 and encephalomyocarditis virus (EMCV) exit Caco-2, HeLa, or baby hamster
kidney (BHK-21) cells through necrotic cell death [88–90].
No signs of apoptosis, such as externalization of phosphatidylserine, pronounced chromatin condensation, DNA fragmentation, caspase cleavage and cytoplasmic blebbing, are
observed in infected cells, yet damage to cell membranes
leading to cell death occurs, suggestive of necrosis. CVB1
induces necrotic death in Caco-2 cells by hijacking the
Ca2+ signalling pathway [88], while during EMCV infection of HeLa and BHK-21, the leader (L) and 2A proteins
induce necrosis and suppress apoptosis for optimal viral
yield [89, 90]. The mechanism of necrosis induction and
the relative importance of apoptosis versus necrosis during
pathogenesis in vivo remain unknown.

Caspase-independent apoptosis

Caspase-independent apoptosis occurs when the mitochondrial membrane potential is disrupted through calcium ion
dysregulation or reactive oxygen species, leading to translocation of apoptotic proteins such as apoptosis-inducing
factor (AIF) and endonuclease G from mitochondria to the
nucleus. This process in turn induces chromatin condensation and/or large-scale DNA fragmentation with no
caspase activation [23, 80, 81]. Generally, the kinetics of
apoptosis are slower with caspase-independence, and cells
are likely to persist longer, since they do not expose phosphatidylserine, which is a detection signal for destruction of
apoptotic cells [82]. RNA viruses known to induce caspase-
independent apoptosis include porcine epidemic diarrhoea
virus (PEDV) and hepatitis C virus [83, 84]. Among non-
enveloped enteric RNA viruses, the family Picornaviridae
members poliovirus and coxsackievirus have been shown
to induce caspase-independent apoptosis in specific cells
for viral release and spread.

In the family Reoviridae, two strains of rotavirus, the simian
strain SA-11 and the porcine strain 1154, lyse MA104 cells
mainly via necrosis [91], whereas the highly cytolytic T3D
reovirus strain kills L-929 cells via necrosis and apoptosis
[92]. Infected cells exhibit signs such as damage to the cell
membrane, which leads to cell content leakage and nuclear
fragmentation without DNA cleavage, indicating that CPE
is due to necrosis but not apoptosis. The kinase activity of
receptor-interacting protein 1 (RIP1) is required for necrosis
during reovirus infection [92], while the cellular factors
necessary for rotavirus-
induced necrosis are unknown.
Future studies are needed to identify viral and host determinants, which pathways are engaged, and what mechanisms
control them.

Poliovirus and CVB3 also induce apoptosis in HeLa cells
without caspase activation [85, 86]. Cells infected with
these viruses exhibit signs of apoptosis such as DNA
fragmentation, chromatin condensation, and nuclear
6
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Collectively, the evidence so far suggests that most
non-enveloped enteric RNA viruses induce cell death
by caspase-dependent apoptosis, while the induction of
caspase-independent apoptosis and necrosis are reported
less often (Table 1). The involvement of the picornavirus 2B
and 3C proteins as inducers of apoptosis provides critical
knowledge for our mechanistic understanding. It is important, however, to note that much of this research has been
performed in transformed cell lines in culture and using
cell culture-adapted virus strains. Thus, validation of findings with clinical isolates and in physiologically relevant
non-transformed cell culture models and/or in vivo will
be important in the future. In addition, much remains
unknown about the identity and mechanisms by which
viral proteins of different viral families induce cell death
either in vitro or in vivo. Furthermore, for those viruses that
can induce cell death by multiple mechanisms, determining
the factors (viral and/or host) that drive engagement of
one pathway over another and the consequences on viral
pathogenesis will add to our fundamental understanding
of virology.

multiple rotavirus particles enclosed in large CD98-positive vesicles (>200 nm) that sediment at 10000 g and have membrane-
exposed phosphatidylserine [10]. Electron microscopy of
phosphatidylserine-positive vesicles pulled down from stools
of rotavirus-infected mouse pups and gnotobiotic piglets also
revealed multiple rotavirus particles enclosed in vesicles, and
fluorescence microscopy has shown that the virus-containing
EVs are microvesicles of >500 nm in diameter. One intriguing
observation was that, at least in MA104 cells, rotavirus particles
are first released non-lytically, while lytic release occurred later
in infection [10]. This suggests that viruses may have the ability
to switch between different release mechanisms. However, how
such a switch might be regulated, the viral and host factors
involved, and the molecular mechanisms employed remain to
be determined in future studies.
Secretory autophagosomes

Secretory autophagosomes are formed when double-
membraned autophagosomes fuse with the plasma membrane,
resulting in release of single-membraned vesicles of about
300–500 nm in diameter [97, 98]. Molecular markers of
secretory autophagosomes include LC3 (an autophagosome
membrane protein) and inverted phosphatidylserine [98].
In particular, picornaviruses are known for their subversion of autophagy, for example they prevent maturation of
autophagosomes to escape degradation and can use this
pathway for non-lytic release [20].

Non-lytic release
In the absence of cell death, egress of non-enveloped enteric
RNA viruses into the extracellular space can also occur
through membranous enclosure of progeny virus and non-
lytic release via vesicles. Extracellular vesicles (EVs) are
released by most eukaryotic and prokaryotic cells to modulate cell behaviour [93, 94], and they originate from different
cellular pathways. Based on size and how they are derived,
EVs are classified into microvesicles, secretory autophagosomes and exosomes [95]. Here, we describe the non-lytic
release of non-enveloped enteric RNA viruses in all three EV
types (Fig. 1). Also discussed is a fourth category (others)
that describes a non-lytic viral release mechanism without
the involvement of EVs.

Non-lytic release of poliovirus was first suggested in the
1950s when researchers observed ‘bubbling’ and vacuolation in infected fibroblasts from adult human tonsils [99].
A decade later, non-lytic poliovirus release by extracellular
vesicles likely derived from the endoplasmic reticulum, the
origin of autophagosome membranes, was shown [100]. This
suggests that the ‘vacuoles’ are likely secretory autophagosomes. The autophagic origin of double-membrane structures
and their association with poliovirus proteins 2C and 3B was
demonstrated many years later [101]. However, the presence
of poliovirus particles within these vesicles was not demonstrated directly until half a century after the original discovery
[19, 21, 102–104]. Detection of LC3 and lysosomal-associated
membrane protein 1 (LAMP-1) on poliovirus capsid-
containing vesicles confirmed the autophagosomal origin of
these vesicles. Efficient poliovirus maturation into infectious
virions relies on the formation of amphisomes (i.e. the fusion
of autophagosome and endosome) [98] and subsequent acidification, since inhibiting acidification reduces the cleavage of
VP0 capsid protein into VP2 and VP4 for maturation in cell
lysates [105]. Hence, autophagic organelles remain mature
and functional during infection. This non-lytic release of cell
contents and virus from poliovirus-infected cells by vesicles of
autophagic origin has been termed autophagosome-mediated
exit without lysis (AWOL) [21]. CVB3 can also be released
from cells in EVs through an AWOL-like pathway in multiple
cell types in vitro [106, 107]. By modulating the autophagy
pathway via inducing formation of autophagosome-
like
vesicles and inhibiting vesicle maturation and its degradative function, CVB3 enhances viral replication [108, 109].

Microvesicles

Microvesicles (MVs) are EVs formed from direct budding
and fission of the plasma membrane into the extracellular space for release of vesicles containing cytoplasmic
contents [96]. Compared to secretory autophagosomes
and exosomes, MVs are the largest EVs, with diameters
ranging from 200 nm to several microns. Like other EVs,
MVs have inverted phosphatidylserine in the membrane
[96] that can be detected by annexin V staining. Specific
universal markers for MVs have not been identified, but
MVs contain markers that depend on the parent cells or
cellular processes that led to their release [96]. For virus
release, virions are enclosed within the ‘bulged out’ cell
membrane alongside other cytoplasmic contents, and the
vesicles then bud off into the extracellular space without
causing cell lysis.
Rotaviruses are released within MVs both in vivo (found in
faeces) and in vitro [10]. Extracellular media from rotavirus-
infected H69 human cholangiocytes and MA104 cells contain
7
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Non-lytic release of picornaviruses using AWOL and generation of vesicles enclosing multiple virions enhances virus
infection by increasing efficient cell-to-cell transmission via
membrane fusion and via increased multiplicity of infection
[102]. This higher local multiplicity of infection may also
increase infectivity in vivo, as was shown for rotavirus [10].
However, future studies are needed to test the importance
of vesicles containing multiple picornaviruses during viral
pathogenesis.

that bile acids and digestive enzymes in the gut destroy
the exosomal membrane prior to faecal shedding and that
exosome-enclosed virions in plasma may be a protective
mechanism shielding the virus from neutralizing antibodies
and enhancing intra-host spread.
In the case of EMCV, non-lytic release of progeny virus in
EVs occurs early during infection of HeLa cells prior to loss
of plasma membrane integrity and cell death [119]. Intriguingly, a variety of EVs that differed in both size and molecular
composition were found to be associated with infectious
EMCV. Size characterization was based on ultracentrifugation at different speeds: 10 000 g for larger EVs (i.e. MVs) and
100 000 g for smaller EVs. These can be further divided into
subpopulations using side and forward scatter via flow cytometry. All EVs associated with EMCV possessed flotillin-1,
CD63 and CD9, which are known markers of exosomes;
but the smaller (100 000 g) EVs also were positive for LC3I/
II, which is a known marker of secretory autophagosomes.
However, since MVs are large EVs that sediment at 10 000 g,
it will be important to widen the array of markers for characterizing these EVs to determine whether EMCV can also be
released in MVs. Thus, the specific EV type(s) involved in the
non-lytic release of EMCV in different cell types as well as the
biological significance of the potential release via different EV
types for viral pathogenesis remain to be identified.

Exosomes

Exosomes are the smallest type of EV (50–200 nm in diameter) and are formed from the fusion of the plasma membrane
with specialized endosomes known as multivesicular bodies
(MVBs) [110]. Exosomes are identified molecularly by a
number of membrane proteins and lipids that are extensively
reviewed elsewhere [111, 112]. Common molecular markers
used to define exosomes are CD63 and CD81 [112]. This
section discusses how the picornaviruses, rotavirus, norovirus
and hepatitis E virus use exosomes to exit cells without lysis.
Picornaviruses HAV, EV71 and EMCV egress cells without
lysis via the exosomal pathway from multiple cell types in
vitro (Table 1) [8, 113, 114] In HAV, the exosome enclosure is
termed a quasi-envelope, and the associated virus is referred
to as eHAV [114]. The exosomal origin of the envelope was
confirmed by he expression of markers, including CD63,
flotillin-1, LC3B and TAPA1, and the finding that knockdown
of proteins that contribute to exosome biogenesis (ALIX and
VPS4B) inhibits the release of HAV [6, 114]. In vivo, the quasi-
envelope shields virions from antibody recognition in blood
and promotes effective spread within the host [115], while
naked particles are shed into the environment and transmitted
to new hosts. Important differences between these two forms
of particles are also observed during entry [116]. Uptake of
both eHAV and nHAV into cells is dependent on clathrin,
dynamin and integrin β1. However, genome release from
nHAV particles occurs earlier from late endosomes relative to
eHAV, which release their genome from lysosomes following
degradation of the quasi-envelope, suggesting a faster replication cycle for nHAV particles. Thus, the two particle types are
optimized for their different roles during spread within and
between hosts, but whether differential kinetics are important
at different stages during pathogenesis remains unknown.

Notwithstanding, it is important to note that EV enclosure of
EMCV significantly protects virus from antibody neutralization, allowing for efficient virus spread and propagation [119].
Collectively, the non-lytic release of some picornaviruses via
exosomes is likely an important factor in viral pathogenesis,
since it confers a replication advantage and presents an
immune escape mechanism.
In addition to picornaviruses, there is also increasing
evidence that noroviruses exit cells using a non-lytic mechanism. Recently, shedding of exosome-enclosed HNoV in
faeces from infected patients was reported [10]. Electron
microscopy revealed small (<200 nm) vesicles containing
between one and five HNoV particles following pull-down
of phosphatidylserine-
containing vesicles from stool of
infected patients [10]. These vesicles displayed exosome-
specific tetraspanins CD63, CD9 and CD81, which are known
markers of multivesicular body (MVB)-derived exosomes
[112, 120]. Similarly, small phosphatidylserine-containing
vesicles containing infectious MNV-1 were isolated from the
extracellular culture media of infected murine macrophages.
The vesicle membranes contained Bis(monoacylglycerol)
phosphate (BMP), a lipid enriched in MVBs and MVB-
derived exosomes [121]. Blocking exosome generation with
GW4869, a neutral sphingomyelinase inhibitor, significantly
reduced MNV-1 release into the cell supernatant, highlighting the role of exosomes during MNV-1 exit from cells.
Very limited or no CPE has been observed during HNoV
infection of human intestinal enteroids [75] and B cells [66],
respectively, consistent with a non-lytic release mechanism.
However, the viral and host factors mediating the release
remain to be investigated.

Similarly, infection of cells with exosome-associated EV71
is more efficient than infection with free virus, as shown by
increased viral RNA and VP1 yields [8]. In addition to this
direct effect, EV71 can also promote its infection indirectly
by inducing the exosome release of a microRNA (miR-30a)
from oral epithelial cells to target MyD88 in macrophages
to inhibit type I interferon production [117]. However,
whether miR-30a-positive exosomes contain EV71 particles
is currently unknown. In vivo, exosome-enclosed EV71 has
been identified in plasma from EV71-infected patients with
viral encephalitis, while naked EV71 has been identified in
stool samples from these same patients [118]. This pattern
of exosome-enclosed virus in the blood and naked virions
in the stool is similar to HAV [115], where it was proposed
8
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Release of quasi-enveloped hepatitis E virus (eHEV) is also
observed in cell culture [122–125]. The quasi-
envelope
contains trans-Golgi network protein 2, is derived from
membranes of MVBs [122, 123] and requires the cytoplasmic
ESCRT machinery [126], impling an exosomal origin of
the membrane. The viral ORF3 protein is important for
membrane association of the virus via interaction with
Tsg101, a cellular player in the ESCRT pathway that is also
involved in the budding of enveloped viruses [126]. Thus,
ORF3 is necessary for optimal release of infectious virus
particles [125, 127–130]. Similar to HAV, HEV particles in
bile and faeces are ‘naked’, while those in blood and culture
supernatants are membrane-cloaked [127, 129, 131]. These
membrane-enclosed virions are able to escape neutralizing
antibodies, allowing for efficient virus spread [9, 131]. Interestingly, the infectivity of eHEV in vitro is lower than that of
nHEV, in part due to reduced cell attachment resulting from
a lack of viral proteins on the surface of the quasi-envelope
[9, 132]. Both nHEV and eHEV enter cells via clathrin-
mediated endocytosis, but only the latter requires Rab5 and
Rab7 activity. In addition, eHEV, but not nHEV, uncoating is
dependent on the lysosomal membrane degradation process
[132]. These data implicate the lysosome in the degradation
of the quasi-envelope and point to two locations for genome
release into the cytosol, i.e. the endosome for nHEV and the
lysosome for eHEV. Taken together, the selective presence
or absence of the HEV exosome-like ‘envelope’ is advantageous during pathogenesis. The non-lytic release of HEV via
exosomes protects the virus from neutralizing antibodies,
thereby allowing viral spread in the blood, while the loss of
the ‘envelope’ in faeces allows for effective transmission of
more infectious nHEV between hosts.

contact the plasma membrane of neighbouring cells. Viral
capsid protein was present in cellular protrusions. Importantly, when fluorescent dextran was co-injected into cells
with CVB3 RNA in the presence of neutralizing antibodies,
viral proteins were observed not only in the microinjected
cells, but also in surrounding cells over time. Thus, these cell-
to-cell protrusions, also called tunnelling nanotubes, represent an alternative way for virus to spread between cells and
to escape neutralizing antibody responses. Additional studies
are needed to elucidate the importance of this mechanism for
viral spread in the host and the cellular and viral regulators
of this process.

In summary, an exosomal origin of membranes surrounding
virions is shared among several different virus families. The
number of virus particles enclosed in these membranes differs
between viruses, which may affect genome complementation
ability and, ultimately, infectivity. Furthermore, while the
naked and enveloped virus particles of HAV and HEV play
similar roles during distinct stages in viral pathogenesis, the
role of each particle type during infection with other viruses,
such as the relevance of naked and enveloped norovirus particles in the stool, remains unknown.

In summary, at least one virus from each of five families of
non-enveloped enteric RNA viruses has been shown to exit
cells without causing lysis (Table 1). Except for astrovirus and
echovirus, there is evidence for the use of EVs for egress in
all other viruses discussed (Fig. 1), implying that the most
common mechanism of non-lytic egress of non-enveloped
enteric RNA viruses is via EVs. Most of the viruses employ
one type of EV for egress, while a few, such as rotavirus and
EMCV, likely exit cells via multiple EV types. More research
is needed to explore egress of non-enveloped viruses via EVs,
especially for viruses such as astroviruses that cause little to
no CPE in permissive cells [143]. In addition, the viral and
host factors that mediate vesicle formation and enclosure for
their non-lytic release, ultimately determining the type of EV
employed for egress, remain to be identified. Some enveloped
viruses such as hepatitis C virus, Epstein–Barr virus and
herpes simplex virus, can be enclosed in exosomes that express
some viral proteins, which facilitate virus entry via membrane
fusion and provide virus-specific cell tropism [144]. However,
viral proteins on EVs formed from the viruses discussed in
this review have not been observed. While the absence of viral
proteins in EVs may reduce specific virus attachment and
infectivity, receptor-independent uptake may be supported
through this mechanism and result in replication beyond the
primary target cells, thus contributing to pathogenesis.

Astroviruses require caspase cleavage for maturation of their
capsids during egress [135]. Surprisingly, though, apoptotic
cell death or other cytopathic effects are not observed in
infected cell cultures, yet infectious particles are detectable in culture supernatants [136–139]. This highlights the
non-apoptotic functions of caspases [140] and implies that
virus egress is non-lytic; however, the mechanism of release
remains to be discovered. Given the understudied nature of
astroviruses, it is conceivable that EVs may mediate non-lytic
virion release, but definitive experiments are needed to test
this hypothesis.
Another virus that can be released non-lytically is echovirus,
but the mechanism of this release is unknown. Some strains of
echovirus do not form plaques at all, while others eventually
induce plaque formation in monkey kidney cells several days
after virus release can be detected [141]. On the other hand,
echovirus causes apoptotic cell death of infected dendritic
cells [142], highlighting the importance of cell type for viral
egress.

Other non-lytic mechanisms
In addition to EV-mediated mechanisms, some viruses are
released without cell lysis in other ways. In this section, we
discuss protrusion-mediated cell-to-cell spread of coxsackie
virus and the undefined non-lytic egress mechanisms of
human astrovirus and echovirus.
Multiple viruses have been observed to form actin-based
connections between cells in culture [133]. Among them,
CVB3 may exit infected green monkey kidney (GMK) cells
directly into neighbouring cells through cell protrusions [134]
without cell lysis. Infection by CVB3 or transfection of CVB3
RNA into cells induces a time-dependent formation of filamentous protrusions of the plasma membrane that eventually
9
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into faeces and virus transmission, while basolateral release
of the virus, which mostly occurs in hepatocytes, contributes
to viraemia.

Polarized cells and directional viral release
Cell polarization is the asymmetric organization of cytoplasmic and membrane-associated domains for specialized
cellular functions [145], such as maintaining a barrier within
an epithelium. Epithelial cell polarity is characterized by
the presence of apical and basolateral membrane domains
separated by adherens and tight junctions, and these domains
have unique protein and phospholipid compositions [146]. A
unique endocytic pathway known as transcytosis and specialized sorting mechanisms occur in polarized cells for transport
of molecules. The development of polarity [147], for example
the asymmetrical distribution of a viral receptor or polarized
sorting, is important for uptake and release of viruses. While
polarized monolayers are viewed as more physiologically
relevant in in vitro culture models compared to traditional
two-dimensional cell culture, the studies to date still rely on
transformed cell lines and mechanistic details into the vectorial aspects of the virus life cycle remain scarce. Below, we
summarize the directional release of select non-enveloped
enteric RNA viruses from polarized epithelial cells via the
apical or basolateral surface (Table 1) and the implications
for viral pathogenesis.

Although HEV has a similar cell tropism to HAV, there are
slight differences in its release and entry patterns. In polarized
hepatocytes (HepG2/C3A), HEV infects the apical and basolateral surface with equal efficiencies, but infectious particle
release occurs almost exclusively from the apical surface
[154], consistent with shedding into bile. Apical release is
also favoured in polarized Caco-2 cells [130]. Both apicaland basolateral-released HEVs are quasi-enveloped [154],
although the mechanism of vesicle formation and release may
be different between the two cell surfaces [155, 156]. These
data indicate that most of the infectious HEV is released into
bile and the intestinal lumen for spread to new hosts, while
basolateral release and viraemia are less pronounced.
Reovirus infection in polarized human respiratory epithelial
cells occurs from the basolateral surface, and virus particles
are released via the apical surface with minimal detectable
disruption of tight junctions [157]. This directional apical
release of reovirus from respiratory epithelial cells may facilitate inter-host transmission via respiratory fluids. Although
signs of apoptosis such as nuclear condensation and DNA
fragmentation were not observed in infected human respiratory epithelial cells, a significant amount of dead cell debris
was released into the mucus membrane and airway surface
liquid [157], suggesting apoptotic extrusions as a possible
apical egress pathway. Apoptotic extrusions help maintain
the epithelial barrier while getting rid of cells ready for
programmed death [158]. Efficient reovirus uptake and
release of polarized human brain microvascular endothelial
cells (HBMECs) occurs from the apical surface, yet few
signs of apoptosis (as measured by TUNEL staining) or lysis
are detected [159]. The mechanism of non-lytic release of
reovirus is still unknown and requires future investigation.

To enter the host, picornaviruses infect the apical surface of
the intestinal epithelium. Within-host spread requires virus
release from the basolateral surface, while apically shed virus
promotes faecal shedding and transmission to new hosts.
In vitro, poliovirus-infected polarized Caco-2 cells release
viral progeny exclusively at the apical surface, while infected
polarized Vero C1008 (green monkey kidney epithelial cells)
cells release viral progeny from both the apical and basolateral
surfaces in the absence of significant cell lysis [148]. However,
virus infection can occur from both apical and basolateral
surfaces for both cell types [148].
Similarly, HAVs are mostly released into the apical supernatant from polarized Caco-2 cells without inducing CPE
[115]. Virus uptake is more efficient at the apical relative
to the basolateral surface, most likely due to the increased
abundance of viral receptors on the apical membrane [3].
Enhanced apical release might contribute to reinfection of
intestinal cells for virus amplification, in addition to shedding
into stool for transmission. By contrast, egress of HAV from
polarized HepG2 hepatocytes after basolateral infection is
more balanced, with approximately twice as much basolateral
versus apical release of particles [115, 149, 150]. However, no
difference in location of release was observed between eHAV
and nHAV [115]. Basolateral release of HAV from hepatocytes directly releases virus into the blood and likely accounts
for viraemia during HAV infection [151, 152], but also amplifies HAV infection of the liver via basolateral reinfection of
hepatocytes [149]. On the other hand, apical release of HAV
from hepatocytes delivers virus into bile, with eventual release
into stool for virus transmission [153]. The apical release has
been described to occur via lysosome-related organelles, in
which virus particles are cleaved for maturation [150]. Taken
together, egress of HAV from the apical surface of polarized
intestinal cells and hepatocytes is important for shedding

The polarity of rotavirus uptake and release is dependent on
the cell model. Polarized intestinal IPEC-J2 cells infected
from the basolateral surface preferentially release virions
apically [160]. However, Caco-2, MDCK-1 and CV-1 cells
are efficiently infected both from apical and basolateral
surfaces [161], with preferential apical release in Caco-2 cells
and bidirectional release from polarized MA104 [162]. The
preferential apical release from intestinal cells in vivo would
result in the excretion of the virus in the faeces for inter-host
transmission, while release from the basolateral surface
would allow for viral spread to underlying tissues, leading to
extra-intestinal infections within the host, antigenaemia, and
viraemia [163–166].
In summary, the directional release of virions from polarized cells is an important determinant of the viral life cycle
and pathogenesis. The data so far on poliovirus, HAV, HEV,
reovirus and rotavirus suggest that polarized intestinal cells
mostly release enteric non-enveloped RNA viruses from the
apical surface (Table 1), which is relevant for the excretion and
transmission of viruses to ensure circulation in the population. On the other hand, release of viruses from polarized
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extra-intestinal cells (hepatocytes and kidney cells) often
occurs from the basolateral surface, which is clinically relevant for the spread of virus to other tissues, possibly leading
to viraemia and disseminated infections. However, understanding the molecular mechanisms that drive directionality
of virus release from polarized cells, including whether viruses
specifically interact with molecules for apical or basolateral
transport, remains an important question for future research.
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